GlobalData’s reports offer expert analysis, insights and opinions to companies in the world’s largest industries. Explore unique market-leading data today and benefit from access to actionable insight within the Ear Nose Throat Disorders market. Reports cover market growth forecasts, trends and research, and more.

Browse our full list of Ear Nose Throat Disorders market reports here.

NEW Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Acute Sensorineural Hearing Loss Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Acute Sensorineural Hearing Loss pipeline landscape. The report...

NEW Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Hearing Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Hearing Disorders pipeline landscape. The report provides comprehensive information on...

NEW Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Rhinitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Rhinitis pipeline landscape. The report provides comprehensive information on the therapeutics...

NEW Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Otitis Externa Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Otitis Externa pipeline landscape. The report provides comprehensive information on...

NEW Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

  • $2,000
  • May 2022
Rhinosinusitis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provides an overview of the Rhinosinusitis pipeline landscape. The report provides comprehensive information on the therapeutics...

NEW Otitis Media Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Otitis Media - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an...

NEW Nasal Polyps (Nasal Polyposis) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyps (Nasal Polyposis) - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update,...

NEW Meniere Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • March 2022
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Meniere Disease - Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update, provides an...

Nasopharyngitis (Common Cold) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • $2,000
  • February 2022
Nasopharyngitis, also known as common cold, is an infectious, inflammatory condition that affects the throat and nasal passages. The virus can spread through droplets in the air when someone who...

Otitis Media – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report provides an overview of the otitis media clinical trials scenario. This report provides top-line data relating to the clinical trials on otitis media. The report includes...